Skip to main content

Table 3 Two-year risk of adverse cardiovascular outcomes after coronary angiography in elective diabetes patients with chronic coronary syndrome

From: Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016

 

Patients

Events

Two-year cumultive incidence proportion (95% CI)

Unadjusted IRR (95% CI)

Adjusted IRR* (95% CI)

MACE

     

2004–2006

1066

89

8.4% (6.9–10.3)

Reference

Reference

2007–2009

1507

126

8.5% (7.2–10.0)

1.01 (0.77–1.33)

0.96 (0.73–1.27)

2010–2012

1523

94

6.2% (5.2–7.6)

0.73 (0.55–1.98)

0.67 (0.50–0.91)

2013–2016

1835

121

6.7% (5.6–7.9)

0.78 (0.59–1.03)

0.70 (0.53–0.93)

Myocardial infarction

   

2004–2006

1066

42

4.0% (3.0–5.4)

Reference

Reference

2007–2009

1507

57

3.9% (3.0–5.0)

0.97 (0.65–1.45)

0.96 (0.64–1.43)

2010–2012

1523

61

4.1% (3.2–5.2)

1.02 (0.69–1.51)

0.97 (0.65–1.44)

2013–2016

1835

66

3.7% (2.9–4.7)

0.91 (0.61–1.34)

0.85 (0.57–1.25)

Ischemic stroke

     

2004–2006

1066

36

3.4% (2.5–4.7)

Reference

Reference

2007–2009

1507

40

2.7% (2.0–3.7)

0.79 (0.50–1.24)

0.76 (0.48–1.21)

2010–2012

1523

24

1.6% (1.1–2.4)

0.46 (0.27–0.78)

0.40 (0.24–0.69)

2013–2016

1835

35

2.0% (1.4–2.7)

0.56 (0.35–0.89)

0.47 (0.29–0.76)

Cardiac death

     

2004–2006

1066

24

2.3% (1.5–3.4)

Reference

Reference

2007–2009

1507

41

2.8% (2.1–3.8)

1.22 (0.74–2.20)

1.12 (0.67–1.87)

2010–2012

1523

17

1.1% (0.7–1.8)

0.50 (0.27–0.92)

0.45 (0.24–0.85)

2013–2016

1835

30

1.7% (1.2–2.4)

0.73 (0.42–1.24)

0.65 (0.38–1.14)

Death

2004–2006

1066

64

6.0% (4.7–7.6)

Reference

Reference

2007–2009

1507

115

7.6% (6.4–9.1)

1.28 (0.95–1.74)

1.21 (0.89–1.64)

2010–2012

1523

85

5.6% (4.5–6.9)

0.93 (0.67–1.28)

0.84 (0.61–1.17)

2013–2016

1835

97

5.3% (4.4–6.4)

0.88 (0.64–1.21)

0.78 (0.56–1.06)

  1. *Adjusted for sex, age, smoking, hypertension, previous ischemic stroke, peripheral artery disease, statin treatment, antiplatelet treatment, and oral anti-coagulant treatment. Ischemic stroke and death were additionally adjusted for atrial fibrillation and heart failure